|
1
|
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria.
|
Hum Reprod
|
2011
|
5.49
|
|
2
|
Fertility and ageing.
|
Hum Reprod Update
|
2005
|
2.68
|
|
3
|
I. The moral status of the pre-implantation embryo.
|
Hum Reprod
|
2001
|
1.73
|
|
4
|
Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review.
|
Hum Reprod Update
|
2005
|
1.66
|
|
5
|
ESHRE Task Force on Ethics and Law 14: equity of access to assisted reproductive technology.
|
Hum Reprod
|
2008
|
1.59
|
|
6
|
Taskforce 8: ethics of medically assisted fertility treatment for HIV positive men and women.
|
Hum Reprod
|
2004
|
1.53
|
|
7
|
High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles.
|
Hum Reprod
|
1999
|
1.41
|
|
8
|
GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study.
|
Hum Reprod
|
2012
|
1.01
|
|
9
|
ESHRE Task Force on Ethics and Law 13: the welfare of the child in medically assisted reproduction.
|
Hum Reprod
|
2007
|
0.97
|
|
10
|
Oocyte cryopreservation for age-related fertility loss.
|
Hum Reprod
|
2012
|
0.95
|
|
11
|
Association of oestrogen receptor alpha polymorphisms and androgen receptor CAG trinucleotide repeats with male infertility: a study in 109 Greek infertile men.
|
Int J Androl
|
2002
|
0.95
|
|
12
|
ESHRE task force on ethics and law 15: cross-border reproductive care.
|
Hum Reprod
|
2008
|
0.94
|
|
13
|
ESHRE Task Force on Ethics and Law 11: Posthumous assisted reproduction.
|
Hum Reprod
|
2006
|
0.94
|
|
14
|
Lifestyle-related factors and access to medically assisted reproduction.
|
Hum Reprod
|
2010
|
0.93
|
|
15
|
ESHRE Task Force on Ethics and Law 12: oocyte donation for non-reproductive purposes.
|
Hum Reprod
|
2007
|
0.92
|
|
16
|
Providing infertility treatment in resource-poor countries.
|
Hum Reprod
|
2009
|
0.90
|
|
17
|
ESHRE Task Force on Ethics and Law 21: genetic screening of gamete donors: ethical issues.
|
Hum Reprod
|
2014
|
0.88
|
|
18
|
ESHRE Task Force on ethics and Law 20: sex selection for non-medical reasons.
|
Hum Reprod
|
2013
|
0.87
|
|
19
|
Intrafamilial medically assisted reproduction.
|
Hum Reprod
|
2011
|
0.84
|
|
20
|
IFFS expert group report on the Whittemore study related to the risk of ovarian cancer associated with the use of infertility agents.
|
Hum Reprod
|
1993
|
0.84
|
|
21
|
Improved techniques for separating motile spermatozoa from human semen. II. An atraumatic centrifugation method.
|
Int J Androl
|
1984
|
0.83
|
|
22
|
ESHRE Task Force on Ethics and Law 10: surrogacy.
|
Hum Reprod
|
2005
|
0.83
|
|
23
|
Endometrial advancement after triggering with recombinant or urinary HCG: a randomized controlled pilot study.
|
Reprod Biomed Online
|
2010
|
0.81
|
|
24
|
Taskforce 5: preimplantation genetic diagnosis.
|
Hum Reprod
|
2003
|
0.80
|
|
25
|
Laparoscopic management of unexpected borderline ovarian tumors in women of reproductive age.
|
Eur J Gynaecol Oncol
|
2012
|
0.80
|
|
26
|
The periovulatory and luteal phase of conception cycles following in vitro fertilization and embryo transfer.
|
Fertil Steril
|
1984
|
0.80
|
|
27
|
Beta-N-acetylhexosaminidase activity in human oocytes and preimplantation embryos.
|
Hum Reprod
|
1992
|
0.78
|
|
28
|
II. The cryopreservation of human embryos.
|
Hum Reprod
|
2001
|
0.78
|
|
29
|
Human chorionic gonadotropin stimulation of estradiol production and androgen antagonism of gonadotropin-stimulated responses in cultured human granulosa-luteal cells.
|
J Clin Endocrinol Metab
|
1986
|
0.78
|
|
30
|
Pituitary-testicular axis in men with beta-thalassaemia major.
|
Hum Reprod
|
1996
|
0.78
|
|
31
|
Preimplantation diagnosis.
|
Hum Reprod
|
1992
|
0.78
|
|
32
|
Ambiguous genitalia, 45,X/46,XY mosaic karyotype, and Y chromosome microdeletions in a 17-year-old man.
|
Fertil Steril
|
2001
|
0.78
|
|
33
|
Paternal sperm concentration and growth and cognitive development in children born with a gestational age more than 32 weeks after assisted reproductive therapy.
|
Hum Reprod
|
2006
|
0.77
|
|
34
|
Azoospermia: clinical, hormonal, and biochemical investigation.
|
Arch Androl
|
1997
|
0.76
|
|
35
|
Congenital obstructive azoospermia in a man with Marfan syndrome.
|
Fertil Steril
|
2001
|
0.75
|
|
36
|
Operative treatment of gynaecologic diseases in puberty: seven years of experience.
|
Clin Exp Obstet Gynecol
|
2013
|
0.75
|
|
37
|
Obstetric outcome in adolescence: a single centre experience over seven years.
|
Clin Exp Obstet Gynecol
|
2013
|
0.75
|
|
38
|
Seminal plasma transferrin in infertile men.
|
Arch Androl
|
1992
|
0.75
|
|
39
|
Psychological interviews in screening couples undergoing in vitro fertilization.
|
Ann N Y Acad Sci
|
1985
|
0.75
|
|
40
|
Galanin in the amniotic fluid and neonatal birth weight: a prospective observational study.
|
J Matern Fetal Neonatal Med
|
2013
|
0.75
|
|
41
|
Pregnancy outcome after assisted fertilization--a short survey.
|
Int J Androl
|
1997
|
0.75
|
|
42
|
Application of image analysis cytometry in follicular fluid cells obtained from in-vitro fertilization cycles: relationships to patient's age, oocyte maturity, fertilizability and in-vitro fertilization outcome.
|
Hum Reprod
|
1996
|
0.75
|
|
43
|
Improved techniques for collecting motile spermatozoa from human semen. I. A self-migratory method.
|
Int J Androl
|
1984
|
0.75
|
|
44
|
Spontaneous pregnancy following therapeutic approach of an infertile man with aspermia/obstructive azoospermia.
|
Arch Androl
|
1999
|
0.75
|
|
45
|
Taskforce 9: the application of preimplantation genetic diagnosis for human leukocyte antigen typing of embryos.
|
Hum Reprod
|
2005
|
0.75
|